The FDA is testing real-time clinical trial reporting in an effort to speed up the drug review and approval process.

Recent data show high interest and use of spiritual practices and manual therapies among older individuals, particularly those with depression.

Higher vitamin D levels in early midlife are associated with lower tau deposition in later midlife among adults without dementia.

The FDA has approved Auvelity (dextromethorphan HBr/bupropion HCl) for Alzheimer disease agitation, providing a non-antipsychotic option based on ADVANCE-1 and ACCORD-2 data.

There is a greater risk for the development of behavioral problems among children born with congenital heart disease.

Adenotonsillectomy appears to be an effective way to resolve obstructive sleep apnea and improve sleep efficacy for many children.

What were the most significant improvements seen in the Myasthenia Gravis-Activities of Daily Living and Quantitative ...

An AI model using fundus photography can accurately determine retinal age, which may be used to predict clinical aging among adults.

Cognitive function may deteriorate preceding cardiovascular events among older adults, highlighting the value of early cognitive screening.